Dr. Emily S Riser , MD
Specialist • Birmingham, AL
509 Brookwood Blvd, Suite 101
Birmingham, AL 352096801
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 10, 2006; this date does not establish years in practice.
-
Published CMS data list 22,015 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2350 — Injection, ocrelizumab, 1 mg: 13,200 service units.
- J2919 — Injection, methylprednisolone sodium succinate, 5 mg: 8,049 service units.
- 99214 — Established patient outpatient office visit: 266 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 10 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 7,028 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Gabapentin — 638 prescription fills, including refills.
- Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) — 467 prescription fills, including refills.
- Baclofen — 435 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 108 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Specialist in Birmingham, AL (2024, 26 clinicians with data). Median for this group: 479. Middle half: 139 to 1,757.
More Medicare Part B services than 95% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: 1,073. Middle half: 294 to 2,658.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 16,239 in 2020 to 22,015 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
509 Brookwood Blvd
Suite 101
Birmingham, AL 352096801
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Alabama Neurology Associates. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Alabama School Of Medicine
1984
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
215 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $696,925 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $553,624 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
8,766 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$5,290,486 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $22,116.50 across 193 records.
By nature of payment (3 largest of 4)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $16,477.50 across 8 records.
- Food and Beverage: $4,195.21 across 182 records.
- Travel and Lodging: $1,348.80 across 2 records.
Reporting-company totals (3 largest of 24)
- TG Therapeutics, Inc.: $18,570.37 across 28 records.
- Neurocrine BioSciences, Inc.: $465.00 across 18 records.
- Biogen, Inc.: $343.24 across 18 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
42 years (graduated 1984)
CMS Doctors and Clinicians data list 1984 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Riser has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Riser as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Birmingham and Alabama
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Specialist in Birmingham, AL (2024, 26 clinicians with data). Median for this group: 479. Middle half: 139 to 1,757.
More Medicare Part B services than 95% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: 1,073. Middle half: 294 to 2,658.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Specialist in Birmingham, AL (2024, 26 clinicians with data). Median for this group: $40,566. Middle half: $20,771 to $102,082.
A higher Medicare-allowed amount than 95% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: $60,469. Middle half: $20,778 to $147,408.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Specialist in Birmingham, AL (2024, 26 clinicians with data). Median for this group: $31,632. Middle half: $15,722 to $75,451.
A higher Medicare payment amount than 95% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: $45,265. Middle half: $15,498 to $105,953.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Specialist in Birmingham, AL (2024, 30 clinicians with data). Median for this group: 247. Middle half: 153 to 1,373.
More Part D prescriptions than 95% of clinicians listed under Specialist in Alabama (2024, 145 clinicians with data). Median for this group: 762. Middle half: 186 to 2,437.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Specialist in Birmingham, AL (2024, 30 clinicians with data). Median for this group: $21,155. Middle half: $4,110 to $90,895.
A higher Part D drug cost than 95% of clinicians listed under Specialist in Alabama (2024, 145 clinicians with data). Median for this group: $41,558. Middle half: $3,769 to $290,757.
91 active clinicians are listed under Specialist with a practice address in Birmingham, AL (545 in Alabama).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Birmingham
5.5% of these 91 clinicians have the CMS telehealth indicator.
29.7% of these 91 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 36% from 16,239 in 2020 to 22,015 in 2024.
- 2020: 16,239
- 2021: 12,398
- 2022: 14,873
- 2023: 769
- 2024: 22,015
-
Medicare-allowed amount
Medicare-allowed amount decreased 14% from $809,875 in 2020 to $696,925 in 2024.
- 2020: $809,875
- 2021: $621,170
- 2022: $771,009
- 2023: $38,780
- 2024: $696,925
-
Paid by Medicare
Paid by Medicare decreased 14% from $641,452 in 2020 to $553,624 in 2024.
- 2020: $641,452
- 2021: $493,088
- 2022: $612,477
- 2023: $25,159
- 2024: $553,624
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 17% from 6,018 in 2020 to 7,028 in 2024.
- 2020: 6,018
- 2021: 5,657
- 2022: 6,002
- 2023: 5,858
- 2024: 7,028
-
30-day fills
30-day fills increased 19% from 7,340 in 2020 to 8,766 in 2024.
- 2020: 7,340
- 2021: 6,810
- 2022: 7,089
- 2023: 7,072
- 2024: 8,766
-
Part D drug cost
Part D drug cost decreased 42% from $9,102,567 in 2020 to $5,290,486 in 2024.
- 2020: $9,102,567
- 2021: $9,161,680
- 2022: $6,234,245
- 2023: $6,183,291
- 2024: $5,290,486
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 261% from $6,132.24 in 2021 to $22,116.50 in 2025.
- 2021: $6,132.24
- 2022: $11,191.45
- 2023: $15,896.31
- 2024: $34,125.38
- 2025: $22,116.50
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 193 records totaling $22,116.50.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $3,712.50 |
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $3,712.50 |
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $3,712.50 |
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $3,712.50 |
| TG Therapeutics, Inc. |
Travel and Lodging
In-kind items and services
|
BRIUMVI | General | $745.00 |
| TG Therapeutics, Inc. |
Travel and Lodging
In-kind items and services
|
BRIUMVI | General | $603.80 |
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $465.00 |
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $465.00 |
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $465.00 |
| TG Therapeutics, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
BRIUMVI | General | $232.50 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $120.52 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $103.20 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $99.96 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
— | General | $94.99 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $86.79 |
| Biogen, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $80.67 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ULTOMIRIS | General | $67.85 |
| TG Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
BRIUMVI | General | $38.91 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Rystiggo | General | $38.61 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Rystiggo | General | $33.85 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $33.45 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Ocrevus Zunovo | General | $32.34 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ULTOMIRIS | General | $31.88 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $31.58 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $31.33 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2350
Injection, ocrelizumab, 1 mg
|
13,200 | 15 | $162.50 | $49.14 |
|
J2919
Injection, methylprednisolone sodium succinate, 5 mg
|
8,049 | 26 | $1.00 | $0.29 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
266 | 185 | $240.16 | $108.05 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
156 | 25 | $210.00 | $52.69 |
|
J2930
Injection, methylprednisolone sodium succinate, up to 125 mg
|
124 | 14 | $20.00 | $5.81 |
|
96366
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
|
79 | 11 | $110.00 | $17.14 |
|
96375
Injection of additional new drug or substance into vein
|
67 | 21 | $68.00 | $13.37 |
|
96415
Administration of chemotherapy into vein, each additional hour
|
32 | 14 | $130.00 | $24.19 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
26 | 16 | $600.00 | $110.83 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
16 | 16 | $304.00 | $147.23 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Gabapentin | Gabapentin | 638 | 23,262 | $8,507.98 | 136 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 467 | 14,682 | $17,317.38 | 67 |
| Baclofen | Baclofen | 435 | 20,240 | $9,167.56 | 98 |
| Clonazepam | Clonazepam | 351 | 11,000 | $1,621.91 | 47 |
| Tizanidine Hcl | Tizanidine Hcl | 298 | 12,228 | $3,696.70 | 64 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 296 | 8,325 | $6,502.35 | 40 |
| Zolpidem Tartrate | Zolpidem Tartrate | 201 | 7,170 | $1,168.41 | 31 |
| Tramadol Hcl | Tramadol Hcl | 185 | 5,115 | $1,439.76 | 38 |
| Alprazolam | Alprazolam | 182 | 6,184 | $971.81 | 22 |
| Dalfampridine Er | Dalfampridine | 146 | 4,920 | $53,115.89 | 21 |
| Topiramate | Topiramate | 139 | 7,380 | $856.01 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 137 | 6,120 | $2,063.45 | 27 |
| Prednisone | Prednisone | 124 | 3,177 | $751.54 | 48 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 119 | 3,996 | $1,215.37 | 28 |
| Methylphenidate Hcl | Methylphenidate Hcl | 114 | 3,600 | $2,798.05 | 18 |
| Gammagard Liquid | Immun Glob G(Igg)/Gly/Iga Ov50 | 114 | 3,073 | $483,138.50 | — |
| Teriflunomide | Teriflunomide | 104 | 3,180 | $45,219.90 | 18 |
| Lorazepam | Lorazepam | 103 | 3,065 | $452.57 | 19 |
| Sodium Chloride | 0.9 % Sodium Chloride | 97 | 2,616 | $444.72 | 15 |
| Promethazine Hcl | Promethazine Hcl | 96 | 1,933 | $1,068.01 | 13 |
| Pregabalin | Pregabalin | 92 | 3,080 | $1,513.82 | 20 |
| Methylprednisolone | Methylprednisolone | 86 | 584 | $715.27 | 52 |
| Trazodone Hcl | Trazodone Hcl | 82 | 4,320 | $442.50 | 21 |
| Donepezil Hcl | Donepezil Hcl | 75 | 4,110 | $527.48 | 21 |
| Kesimpta Pen | Ofatumumab | 74 | 2,176 | $682,696.67 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEUROLOGY
I20081218000193
AL
3779483664
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Alabama Neurology Associates
3105 Independence Dr, Birmingham, AL 352094111
Phone: 20580322103
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Speech-Language Pathologist
Speech-Language Pathologist
Physical Therapist
PHYSICALTHERAPIST
Physical Medicine & Rehabilitation
Doctor of Osteopathic Medicine (D.O.)
Psychiatry & Neurology - Neurology
Doctor of Medicine (M.D.)
Specialist
Physical Therapist
Physical Therapist
Career & Practice History
NPI enumerated October 10, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Birmingham
- Dr. Hector Caballero, MD
- Dr. Michael Beckenstein, MD
- Dr. Robert Oliver, MD
- Dr. William Thompson, MD
- Dr. Paul Howard, MD
- Dr. Judith Bowen, MD
Mailing Address
509 Brookwood Blvd, Suite 101
Birmingham, AL 352096801
Phone: 2058032210